Skip to content
Delayed ~15 min

BCAX BICARA THERAPEUTICS INC

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Mon 9 Nov 2026 · before market open

What 21 analyst firms say about BICARA THERAPEUTICS INC: their latest ratings, price targets and how far the stock is from them. How it works

8.65 USD+0.46 (+5.62%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+275.2%to the avg target 32.45 USD+23.80 USD
Buy 15 · Hold 4 · Sell 1

20 rated views · 21 analyst/firm records · 21 firms

Latest report29 Oct 2026avg report date 13 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8069
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041

Recent analyst activity · last 90 days

Our tracked history has 19 reports on BCAX from 13 analyst firms in the last 90 days (21 firms in the past year).

Comparing each firm's latest target with its previous one: 4 raised their price target, 1 lowered it, 2 left it unchanged and 1 has its first observed target in the past year.

Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.

Latest observed target change: Wedbush lowered its target from $33.00 (set 12 Aug 2026) to $24.00 on 29 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesTazeen AhmadBuy25 Mar 202635.00 USD
BenchmarkUnnamed analystBuy29 Oct 2026—
BMO Capital MarketsDavid LebowitzBuy18 Aug 202635.00 USD
BTIGJeet MukherjeeBuy19 Oct 202639.00 USD
Cantor FitzgeraldEric SchmidtBuy10 Sep 2026—
CitigroupUnnamed analystBuy21 Aug 2026—
Citizens JMPReni BenjaminBuy31 Mar 202631.00 USD
Goldman SachsRichard LawSell30 Oct 2026Conflicting reports · excluded
GuggenheimBrad CaninoBuy11 May 202642.00 USD
H.C. WainwrightRobert BurnsBuy1 Jun 202642.00 USD
HSBCUnnamed analystHold22 Sep 2026—
JonestradingSoumit RoyBuy1 Jul 202630.00 USD
MizuhoJoseph CatanzaroHold12 Aug 202620.00 USD
Morgan StanleySean LaamanBuy20 Oct 2026—
Piper SandlerKelsey GoodwinBuy11 Aug 202636.00 USD
TD CowenTyler Van BurenBuy15 Jun 2026—
UBSUnnamed analystBuy14 Jan 2026—
WedbushDavid NierengartenBuy29 Oct 202624.00 USD
Weiss RatingsUnnamed analyst—2 Oct 2026—
Wells FargoEva Fortea-VerdejoHold12 Aug 202623.00 USD
Data feed RESEARCHResearch TeamHold14 Apr 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.